Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5

Biochemical Pharmacology

Volumn 84, Issue 8, 2012, Pages 985-993

  Arif, Abul ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cdk5; EPRS; Extraneuronal; Inflammation; p35; p39; Translation control

Indexed keywords

AG 024322; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; AT 7519; CYCLIN DEPENDENT KINASE 5; FLAVOPIRIDOL; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE DEACETYLASE; INDISULAM; INITIATION FACTOR 4G; INSULIN; MRL 24; NEU DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P25; PROTEIN P35; PROTEIN P39; ROSCOVITINE; ROSIGLITAZONE; SCG 727965; STAT3 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ANGIOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MIGRATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLIA CELL; HEMATOPOIETIC CELL; HUMAN; INSULIN RELEASE; MACROPHAGE; METASTASIS; NEOPLASM; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; RNA TRANSLATION; WOUND HEALING;

EID: 84866131320     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.06.027     Document Type: Note

References (86)

1. M. Malumbres, and M. Barbacid Mammalian cyclin-dependent kinases Trends Biochem Sci 30 2005 630 641 (Pubitemid 41540083)
2. M. Malumbres, E. Harlow, T. Hunt, T. Hunter, J.M. Lahti, and G. Manning Cyclin-dependent kinases: a family portrait Nat Cell Biol 11 2009 1275 1276
3. D. Santamaria, C. Barriere, A. Cerqueira, S. Hunt, C. Tardy, and K. Newton Cdk1 is sufficient to drive the mammalian cell cycle Nature 448 2007 811 815 (Pubitemid 47266342)
4. C. Berthet, and P. Kaldis Cell-specific responses to loss of cyclin-dependent kinases Oncogene 26 2007 4469 4477 (Pubitemid 47037044)
5. G. Davidson, and C. Niehrs Emerging links between CDK cell cycle regulators and Wnt signaling Trends Cell Biol 20 2010 453 460
6. R. Dhavan, and L.H. Tsai A decade of CDK5 Nat Rev Mol Cell Biol 2 2001 749 759 (Pubitemid 33679837)
7. V. Lalioti, D. Pulido, and I.V. Sandoval Cdk5, the multifunctional surveyor Cell Cycle 9 2010 284 311
8. S. Cicero, and K. Herrup Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation J Neurosci 25 2005 9658 9668 (Pubitemid 41510906)
9. S.-i. Hisanaga, and K. Ishiguro N.Y. Ip, L.-H. Tsai, The kinase activity of Cdk5 and its regulation cyclin dependent kinase 5 (Cdk5) 2008 Springer US 171 190
10. C. Tarricone, R. Dhavan, J. Peng, L.B. Areces, L.H. Tsai, and A. Musacchio Structure and regulation of the CDK5-p25(nck5a) complex Mol Cell 8 2001 657 669
11. E. Contreras-Vallejos, E. Utreras, and C. Gonzalez-Billault Going out of the brain: non-nervous system physiological and pathological functions of Cdk5 Cell Signal 24 2012 44 52
12. T.K. Pareek, E. Lam, X. Zheng, D. Askew, A.B. Kulkarni, and M.R. Chance Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis J Exp Med 207 2010 2507 2519
13. S. van den Heuvel, and E. Harlow Distinct roles for cyclin-dependent kinases in cell cycle control Science 262 1993 2050 2054 (Pubitemid 24041887)
14. L.H. Tsai, I. Delalle, V.S. Caviness Jr., and T. Chae Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 Nature 371 1994 419 423 (Pubitemid 24302556)
15. J.L. Rosales, and K.Y. Lee Extraneuronal roles of cyclin-dependent kinase 5 Bioessays 28 2006 1023 1034 (Pubitemid 44570451)
16. S.C. Su, and L.H. Tsai Cyclin-dependent kinases in brain development and disease Annu Rev Cell Dev Biol 27 2011 465 491
17. M. Hirasawa, T. Ohshima, S. Takahashi, G. Longenecker, Y. Honjo, and Veeranna Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects Proc Natl Acad Sci USA 101 2004 6249 6254 (Pubitemid 38520560)
18. J. Ko, S. Humbert, R.T. Bronson, S. Takahashi, A.B. Kulkarni, and E. Li p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment J Neurosci 21 2001 6758 6771 (Pubitemid 32781119)
19. J. Liebl, R. Furst, A.M. Vollmar, and S. Zahler Twice switched at birth: cell cycle-independent roles of the neuron-specific cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells Cell Signal 23 2011 1698 1707
20. A. Arif, J. Jia, R.A. Moodt, P.E. DiCorleto, and P.L. Fox Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control Proc Natl Acad Sci USA 108 2011 1415 1420
21. H. Lin, M.C. Chen, C.Y. Chiu, Y.M. Song, and S.Y. Lin Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells J Biol Chem 282 2007 2776 2784 (Pubitemid 47084342)
22. S. Courapied, H. Sellier, S. de Carne Trecesson, A. Vigneron, A.C. Bernard, and E. Gamelin The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition J Biol Chem 285 2010 26765 26778
23. A.K. Fu, W.Y. Fu, J. Cheung, K.W. Tsim, F.C. Ip, and J.H. Wang Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction Nat Neurosci 4 2001 374 381 (Pubitemid 32260113)
24. A.K. Fu, W.Y. Fu, A.K. Ng, W.W. Chien, Y.P. Ng, and J.H. Wang Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity Proc Natl Acad Sci USA 101 2004 6728 6733 (Pubitemid 38586042)
25. X. Yan, and J.P. Morgan Neuregulin1 as novel therapy for heart failure Curr Pharm Des 17 2011 1808 1817
26. M. Ubeda, D.M. Kemp, and J.F. Habener Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells Endocrinology 145 2004 3023 3031 (Pubitemid 38686252)
27. F. Chen, Q. Wang, X. Wang, and G.P. Studzinski Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation Cancer Res 64 2004 5425 5433 (Pubitemid 39006565)
28. G.P. Studzinski, E. Garay, R. Patel, J. Zhang, and X. Wang Vitamin D receptor signaling of monocytic differentiation in human leukemia cells: role of MAPK pathways in transcription factor activation Curr Top Med Chem 6 2006 1267 1271 (Pubitemid 44110915)
29. M. Gallazzini, G.E. Heussler, M. Kunin, Y. Izumi, M.B. Burg, and J.D. Ferraris High NaCl-induced activation of CDK5 increases phosphorylation of the osmoprotective transcription factor TonEBP/OREBP at threonine 135, which contributes to its rapid nuclear localization Mol Biol Cell 22 2011 703 714
30. I. Ugrinova, I.G. Pashev, and E.A. Pasheva Cyclin-dependent kinase 5 phosphorylates mammalian HMGB1 protein only if acetylated J Biochem 149 2011 563 568
31. N. Berberich, B. Uhl, J. Joore, U.K. Schmerwitz, B.A. Mayer, and C.A. Reichel Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9 Br J Pharmacol 163 2011 1086 1098
32. A. Dey, E.T. Wong, C.F. Cheok, V. Tergaonkar, and D.P. Lane R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy Cell Death Differ 15 2008 263 273
33. F.N. Hsu, M.C. Chen, M.C. Chiang, E. Lin, Y.T. Lee, and P.H. Huang Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5 J Biol Chem 286 2011 33141 33149
34. H.R. Seo, J. Kim, S. Bae, J.W. Soh, and Y.S. Lee Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1 J Biol Chem 283 2008 15601 15610
35. Z. Li, G. David, K.W. Hung, R.A. DePinho, A.K. Fu, and N.Y. Ip Cdk5/p35 phosphorylates mSds3 and regulates mSds3-mediated repression of transcription J Biol Chem 279 2004 54438 54444 (Pubitemid 40053183)
36. P.T. Martin Role of transcription factors in skeletal muscle and the potential for pharmacological manipulation Curr Opin Pharmacol 3 2003 300 308 (Pubitemid 36686772)
37. R. Mukhopadhyay, J. Jia, A. Arif, P.S. Ray, and P.L. Fox The GAIT system: a gatekeeper of inflammatory gene expression Trends Biochem Sci 34 2009 324 331
38. A. Arif, J. Jia, R. Mukhopadhyay, B. Willard, M. Kinter, and P.L. Fox Two-site phosphorylation of EPRS coordinates multimodal regulation of noncanonical translational control activity Mol Cell 35 2009 164 180
39. K. Vyas, S. Chaudhuri, D.W. Leaman, A.A. Komar, A. Musiyenko, and S. Barik Genome-wide polysome profiling reveals an inflammation-responsive posttranscriptional operon in gamma interferon-activated monocytes Mol Cell Biol 29 2009 458 470
40. J.H. Song, C.X. Wang, D.K. Song, P. Wang, A. Shuaib, and C. Hao Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway J Biol Chem 280 2005 12896 12901
41. K.Y. Lee, L. Liu, Y. Jin, S.B. Fu, and J.L. Rosales Cdk5 mediates vimentin ser56 phosphorylation during GTP-induced secretion by neutrophils J Cell Physiol 227 2012 739 750
42. J. Du, N. Wei, T. Guan, H. Xu, J. An, and K.A. Pritchard Jr. Inhibition of CDKS by roscovitine suppressed LPS-induced*NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages Am J Physiol Cell Physiol 297 2009 C742 C749
43. D.H. Cho, J. Seo, J.H. Park, C. Jo, Y.J. Choi, and J.W. Soh Cyclin-dependent kinase 5 phosphorylates endothelial nitric oxide synthase at serine 116 Hypertension 55 2010 345 352
44. S. Moriceau, G. Lenoir, and V. Witko-Sarsat In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance J Innate Immun 2 2010 260 266
45. S. Takahashi, T. Ohshima, M. Hirasawa, T.K. Pareek, T.H. Bugge, and A. Morozov Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration Am J Pathol 176 2010 320 329
46. Q. Pan, F. Qiao, C. Gao, B. Norman, L. Optican, and P.S. Zelenka Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75) Cell Mol Life Sci 68 2011 3425 3436
47. F.Y. Wei, K. Nagashima, T. Ohshima, Y. Saheki, Y.F. Lu, and M. Matsushita Cdk5-dependent regulation of glucose-stimulated insulin secretion Nat Med 11 2005 1104 1108 (Pubitemid 41486833)
48. X.H. Lowman, M.A. McDonnell, A. Kosloske, O.A. Odumade, C. Jenness, and C.B. Karim The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose Mol Cell 40 2010 823 833
49. H.Y. Lee, H. Jung, I.H. Jang, P.G. Suh, and S.H. Ryu Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion Cell Signal 20 2008 1787 1794
50. S. Schubert, K.P. Knoch, J. Ouwendijk, S. Mohammed, Y. Bodrov, and M. Jager beta2-Syntrophin is a Cdk5 substrate that restrains the motility of insulin secretory granules PLoS One 5 2010 e12929
51. V. Lalioti, G. Muruais, A. Dinarina, J. van Damme, J. Vandekerckhove, and I.V. Sandoval The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes Proc Natl Acad Sci USA 106 2009 4249 4253
52. S. Okada, E. Yamada, T. Saito, K. Ohshima, K. Hashimoto, and M. Yamada CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation J Biol Chem 283 2008 35455 35463
53. M. Daval, T. Gurlo, S. Costes, C.J. Huang, and P.C. Butler Cyclin-dependent kinase 5 promotes pancreatic beta-cell survival via Fak-Akt signaling pathways Diabetes 60 2011 1186 1197
54. C.M. Sahlgren, A. Mikhailov, S. Vaittinen, H.M. Pallari, H. Kalimo, and H.C. Pant Cdk5 regulates the organization of Nestin and its association with p35 Mol Cell Biol 23 2003 5090 5106 (Pubitemid 36793352)
55. C.S. Busso, C.M. Wedgeworth, and T. Izumi Ubiquitination of human AP-endonuclease 1 (APE1) enhanced by T233E substitution and by CDK5 Nucleic Acids Res 39 2011 8017 8028
56. C. Huang, Z. Rajfur, N. Yousefi, Z. Chen, K. Jacobson, and M.H. Ginsberg Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration Nat Cell Biol 11 2009 624 630
57. T. Harada, T. Morooka, S. Ogawa, and E. Nishida ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 Nat Cell Biol 3 2001 453 459 (Pubitemid 32422080)
58. R.J. McEvilly, M.O. de Diaz, M.D. Schonemann, F. Hooshmand, and M.G. Rosenfeld Transcriptional regulation of cortical neuron migration by POU domain factors Science 295 2002 1528 1532 (Pubitemid 34174009)
59. A. Nohara, S. Okada, K. Ohshima, J.E. Pessin, and M. Mori Cyclin-dependent kinase-5 is a key molecule in tumor necrosis factor-alpha-induced insulin resistance J Biol Chem 286 2011 33457 33465
60. R.M. Myers, J. Stamatoyannopoulos, M. Snyder, I. Dunham, R.C. Hardison, and B.E. Bernstein A user's guide to the encyclopedia of DNA elements (ENCODE) PLoS Biol 9 2011 e1001046
61. J. Zhang, H. Li, O. Yabut, H. Fitzpatrick, G. D'Arcangelo, and K. Herrup Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex J Neurosci 30 2010 5219 5228
62. C.J. Schoenherr, and D.J. Anderson The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes Science 267 1995 1360 1363
63. G.N. Patrick, P. Zhou, Y.T. Kwon, P.M. Howley, and L.H. Tsai p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway J Biol Chem 273 1998 24057 24064 (Pubitemid 28435748)
64. S. Hisanaga, and T. Saito The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator Neurosignals 12 2003 221 229 (Pubitemid 37548237)
65. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, and L.H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364 (Pubitemid 30337070)
66. H. Patzke, and L.H. Tsai Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29 J Biol Chem 277 2002 8054 8060 (Pubitemid 34968258)
67. K.T. Shetty, S. Kaech, W.T. Link, H. Jaffe, C.M. Flores, and S. Wray Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5 J Neurochem 64 1995 1988 1995
68. M. Miyajima, H.O. Nornes, and T. Neuman Cyclin E is expressed in neurons and forms complexes with cdk5 Neuroreport 6 1995 1130 1132
69. Y. Xiong, H. Zhang, and D. Beach D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA Cell 71 1992 505 514
70. P.T. Brinkkoetter, P. Olivier, J.S. Wu, S. Henderson, R.D. Krofft, and J.W. Pippin Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells J Clin Invest 119 2009 3089 3101
71. Y. Taniguchi, J.W. Pippin, H. Hagmann, R.D. Krofft, A.M. Chang, and J. Zhang Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes Am J Physiol Renal Physiol 302 2012 F1161 F1171
72. J. Odajima, Z.P. Wills, Y.M. Ndassa, M. Terunuma, K. Kretschmannova, and T.Z. Deeb Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation Dev Cell 21 2011 655 668
73. T. Kim, V. Law, J.L. Rosales, and K.Y. Lee Cdk5 variant 1 (cdk5-v1), but not full-length cdk5, is a centrosomal protein Cell Cycle 9 2010 2251 2253
74. Q. Li, X. Liu, M. Zhang, G. Ye, Q. Qiao, and Y. Ling Characterization of a novel human CDK5 splicing variant that inhibits Wnt/beta-catenin signaling Mol Biol Rep 37 2010 2415 2421
75. S. Moncini, A. Bevilacqua, M. Venturin, C. Fallini, A. Ratti, and A. Nicolin The 3′ untranslated region of human cyclin-dependent kinase 5 regulatory subunit 1 contains regulatory elements affecting transcript stability BMC Mol Biol 8 2007 111
76. S. Moncini, A. Salvi, P. Zuccotti, G. Viero, A. Quattrone, and S. Barlati The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration PLoS One 6 2011 e20038
77. P.S. Ray, and P.L. Fox A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity EMBO J 26 2007 3360 3372 (Pubitemid 47123539)
78. Z.H. Cheung, and N.Y. Ip Cdk5: a multifaceted kinase in neurodegenerative diseases Trends Cell Biol 22 2012 169 175
79. E. Zeggini, M.N. Weedon, C.M. Lindgren, T.M. Frayling, K.S. Elliott, and H. Lango Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes Science 316 2007 1336 1341 (Pubitemid 46871654)
80. J.H. Choi, A.S. Banks, J.L. Estall, S. Kajimura, P. Bostrom, and D. Laznik Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5 Nature 466 2010 451 456
81. P. Li, W. Fan, J. Xu, M. Lu, H. Yamamoto, and J. Auwerx Adipocyte NCoR knockout decreases PPARgamma phosphorylation and enhances PPARgamma activity and insulin sensitivity Cell 147 2011 815 826
82. P.S. Zelenka Regulation of cell adhesion and migration in lens development Int J Dev Biol 48 2004 857 865 (Pubitemid 40039176)
83. H. Galons, N. Oumata, and L. Meijer Cyclin-dependent kinase inhibitors: a survey of recent patent literature Expert Opin Ther Pat 20 2010 377 404
84. C.J. Strock, J.I. Park, E.K. Nakakura, G.S. Bova, J.T. Isaacs, and D.W. Ball Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells Cancer Res 66 2006 7509 7515 (Pubitemid 44289205)
85. H.S. Choi, Y. Lee, K.H. Park, J.S. Sung, J.E. Lee, and E.S. Shin Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population J Hum Genet 54 2009 298 303
86. S. Lapenna, and A. Giordano Cell cycle kinases as therapeutic targets for cancer Nat Rev Drug Discov 8 2009 547 566